December 9, 2020
932
2
0.21%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
5:57Now PlayingArguably, no region in the world has been hit as hard by the virus as Latin America. At the best of times, its health systems are wobbly. This pandemic year, with Brazil registering the world’s second-highest Covid death toll and Mexico the highest case-fatality ratio, they’re unraveling, aggravating rising inequality, crime, economic decline and public mistrust. With 8% of the globe’s population and 30% of its Covid deaths, Latin America is facing the pandemic’s next phase -- mass vaccination -- with alarm.
“Vaccine distribution will be complicated in developed countries but in Latin America you have to add a lack of transparency, lack of governance and corruption,” said Sergio Litewka, director of global bioethics at the University of Miami. “Will the same people who were incapable of handling the pandemic be able to handle the vaccine?”
There are problems that will affect all countries. Pfizer Inc. just announced that supply chain snags will halve this month’s distribution from original plans. Interpol has issued a global alert saying organized crime networks are targeting Covid-19 vaccines, both physically and online, around the globe.
But Latin America, apart from a couple countries, appears more vulnerable than other regions. The virus has set back decades of gains in democracy and equality, and nearly tripled the number facing food insecurity. Given how poorly the region has fared over the past nine months and the ultra-cold equipment needed to store and transport two of the proven vaccines, many of its health leaders expect it to lag behind, with the risk of more virus waves still ahead.
Of the three vaccine front-runners, Pfizer’s and Moderna Inc.’s have shown 95% effectiveness but their costs and the temperature requirements might prove prohibitive. That leaves AstraZeneca Plc. The shot developed with the University of Oxford accounts for more than 40% of the supplies going to lower- and middle-income nations, based on deals tracked by London-based research firm Airfinity Ltd.
Subscribe to our YouTube channel
Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
To watch complete coverage on Bloomberg Quicktake 24/7, visit or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.
Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake
Connect with us on…
Breaking News on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.